within Pharmacolibrary.Drugs.ATC.R;

model R03DB05
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 4.3333333333333334e-05,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03DB05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Aminophylline is a theophylline derivative combined with ethylenediamine; it is a bronchodilator used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Adrenergics refer to a variety of drugs (e.g., ephedrine, salbutamol) that stimulate adrenergic receptors, often included in combination inhalers to provide additional bronchodilation. The combination is used for acute and chronic bronchospasm. It is less commonly used today due to the availability of newer, safer bronchodilators.</p><h4>Pharmacokinetics</h4><p>No direct pharmacokinetic studies are published for the fixed combination of aminophylline and adrenergics under ATC R03DB05. The following values are estimated based on published data for aminophylline (administered intravenously to healthy adults). Adrenergic PK parameters are not included. For single-dose intravenous aminophylline in adults.</p><h4>References</h4><ol><li><p>Asheim, P, et al., &amp; Aadahl, P (2008). Pharmacokinetics of intraperitoneally instilled aminophylline, terbutaline and tobramycin in pigs. <i>Acta anaesthesiologica Scandinavica</i> 52(2) 243–248. DOI:<a href=&quot;https://doi.org/10.1111/j.1399-6576.2007.01535.x&quot;>10.1111/j.1399-6576.2007.01535.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18005375/&quot;>https://pubmed.ncbi.nlm.nih.gov/18005375</a></p></li><li><p>Dalabih, AR, et al., &amp; Arnold, DH (2014). Aminophylline infusion for status asthmaticus in the pediatric critical care unit setting is independently associated with increased length of stay and time for symptom improvement. <i>Pulmonary pharmacology &amp; therapeutics</i> 27(1) 57–61. DOI:<a href=&quot;https://doi.org/10.1016/j.pupt.2013.03.001&quot;>10.1016/j.pupt.2013.03.001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23523660/&quot;>https://pubmed.ncbi.nlm.nih.gov/23523660</a></p></li><li><p>Igarashi, T, &amp; Iwakawa, S (2009). Effect of gender on theophylline clearance in the asthmatic acute phase in Japanese pediatric patients. <i>Biological &amp; pharmaceutical bulletin</i> 32(2) 304–307. DOI:<a href=&quot;https://doi.org/10.1248/bpb.32.304&quot;>10.1248/bpb.32.304</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19182395/&quot;>https://pubmed.ncbi.nlm.nih.gov/19182395</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03DB05;
